Janina Soler Wenglein

Dr. Janina Soler Wenglein

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2025 in Viruses
Verified
Journal Article
Open access
PDF file
JWJanina Soler Wenglein
Janina Soler Wenglein
LSLuca Scarsella
Luca Scarsella
CKChristine Kotlewski
Christine Kotlewski
AHAlbert Heim
Albert Heim
MAMalik Aydin
Malik Aydin
Human adenoviruses (HAdVs) are pathogens causing different illnesses, particularly in pediatric and immunocompromised patients in developed countries. The clinical spectrum of HAdV-infections ranges from mild to severe, and the clinical presentation varies widely. Certain HAdVs types, including types B3, E4, B7, B14, B21, G55, and B66, may be associated with lower respiratory tract infections and thus lead to higher hospitalization, increased morbidity, as well as lethality rates. The aim of this article is to synthesize and analyze the prevalence of specific HAdV types in pediatric patients worldwide. A systematic literature search was performed using MEDLINE, Scopus, and Web of Science. In total, n = 1167 titles and abstracts were screened, and 105 full-text articles were assessed for eligibility. Screening, data extraction, and appraisal were analyzed by reviewers, in accordance with PRISMA guidelines and JBI recommendations. We included studies reporting on currently circulating HAdV types (n = 16). Based on a systematic and narrative approach, relevant types of HAdV biology and infections in children are presented. In detail, HAdV-B3 and HAdV-B7 were commonly associated with severe respiratory tract infections, while HAdV-F40 and HAdV-F41 caused acute gastroenteritis. Moreover, detailed research revealed the critical role of HAdV-C2 and the necessity for particular attention to HAdVs in acute neurological infections. This comprehensive analysis highlights the significant global distribution and diverse clinical implications of different HAdV types in children, pointing out the need for continued surveillance to better understand HAdVs epidemiology and its implications for public health, and future preventive measures, in particular among vulnerable patients.

13 July 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
JWJanina Soler Wenglein
Janina Soler Wenglein
GKGerhard Kluger
Gerhard Kluger
FLFrank Leypoldt
Frank Leypoldt
KWKlaus-Peter Wandinger
Klaus-Peter Wandinger
ABAndreas van Baalen
Andreas van Baalen
The pediatric febrile infection-related epilepsy syndrome (FIRES) manifests with encephalopathy with super-refractory status epilepticus (SE) a few days after or accompanying a febrile illness. It often results in refractory epilepsy and cognitive dysfunction in previously healthy children and adolescents. The underlying pathomechanism is unknown, which is why causative neuronal and/or synaptic antibodies have been discussed. We report a prospective consecutive cohort of 14 children (10 male, four female) diagnosed with FIRES in the acute phase, whose serum and CSF were comprehensively screened for underlying synaptic/neuronal autoantibodies. The median age at onset was 6 years (range 4–9 years). None of the children had a medical history of epilepsy. Duration of SE varied from less than 1 week to 2.5 months (Median: 1 month, range < 1 week-2.5 months). Clinical response to treatment with antiseizure medications was poor as well as the outcome: one child died in the acute phase of SE, and two died in the long term. All surviving children showed neuropsychological impairments. No underlying synaptic or neuronal autoantibodies were identified in 13 of 14 children’s sera or CSF. One child had currently uncharacterized neuronal autoantibodies in CSF, yet clinical presentation was atypical for FIRES. Based on our findings, the child was later diagnosed with autoimmune encephalitis (AE). We conclude that FIRES is not an autoantibody-mediated disease. However, a comprehensive screening for known and yet unknown antineuronal antibodies in serum and CSF is warranted to rule out AE mimicking FIRES.

7 January 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
MDMarie-Theres Dammann
Marie-Theres Dammann
HKHannah Kraft
Hannah Kraft
GSGuido Stichtenoth
Guido Stichtenoth
KHKathrin Hanke
Kathrin Hanke
MZMichael Zemlin
Michael Zemlin
ONOn Behalf Of The German Neonatal Network
On Behalf Of The German Neonatal Network
Background: Very-low-birth-weight infants (VLBWIs; birth weight < 1500 g) are at an increased risk of complicated influenza infection, which frequently includes pneumonia, encephalitis or even death. Data on influenza immunization and its outcome in VLBWIs are scarce. This study aimed to provide epidemiological data on influenza immunization for German VLBWIs and hypothesized that immunization would protect VLBWIs from infection-mediated neurodevelopmental impairment and preserves lung function at early school age. Methods: In this observational population-based German Neonatal Network (GNN) study, infants born between 2009 and 2015 were invited to partake in a 6-year follow-up investigation including lung function and developmental testing. Uni- and multivariate analyses were performed to evaluate the clinical characteristics and outcomes of influenza-immunized VLBWIs compared to non-immunized VLBWIs. Results: Influenza immunization was performed in 871 out of the 3358 VLBWIs (26%) with six-year follow-up. Immunized infants were characterized by a low gestational age and higher rates of morbidity, particularly bronchopulmonary dysplasia. Although early immunization showed no safety signals and had protective effects on the long-term risk of bronchitis (OR: 0.2; CI: 0.1–0.6; p = 0.002), most VLBWIs (88.0%) were unimmunized in their first influenza season. Conclusions: Influenza immunization was not associated with improved lung function (forced expiratory volume in one second and forced vital capacity) or a better neurocognitive outcome (intelligence quotient and strengths and difficulties questionnaire) at early school age. In Germany, only one quarter of 6-year-old VLBWIs were immunized against influenza, particularly those born <28 gestational weeks and/or BPD. Specific influenza immunization guidelines that define evidence-based recommendations are needed for this vulnerable group.

24 October 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
JWJanina Soler Wenglein
Janina Soler Wenglein
RBReinhard Bornemann
Reinhard Bornemann
JHJohannes Hartmann
Johannes Hartmann
MHMarkus Hufnagel
Markus Hufnagel
RTRoland Tillmann
Roland Tillmann
Antimicrobial resistance (AMR) constitutes a major global health challenge, driven significantly by inappropriate antibiotic use in human medicine. Despite the existence of evidence-based guidelines, variability in antibiotic prescribing persists, influenced by psychosocial factors, diagnostic uncertainty, patient expectations, and local prescribing cultures. Outpatient care, the setting in which most antibiotics are prescribed, is particularly affected by such challenges. Traditional top-down interventions, such as national guidelines, often fail to achieve sustained behavioral change among prescribers. In this comprehensive review, we provide an overview of the psychological and behavioral factors influencing antimicrobial stewardship (AMS) implementation, as well as describe a bottom-up project working to meet these challenges: the “Antibiotic Therapy in Bielefeld” (AnTiB) initiative. AnTiB employs a cross-sectoral strategy aimed at developing rational prescribing culture by means of locally developed consensus guidelines, interdisciplinary collaboration, and regularly held trainings. By addressing both the organizational and psychological aspects of prescribing practices, AnTiB has facilitated a harmonization of antibiotic use across specialties and care interfaces at the local level. The initiative’s success has led to its expansion within Germany, including through the creation of the AMS-Network Westphalia Lippe and the development of AnTiB-based national pediatric recommendations. These projects are all grounded in social structures designed to strengthen the long-term establishment of AMS measures. Our efforts underscore the importance of considering local social norms, professional network, and real-world practice conditions in AMS interventions. Integrating behavioral and social science approaches into outpatient antimicrobial stewardship—exemplified by the practitioner-led AnTiB model—improves acceptability and alignment with stewardship principles; wider adoption will require local adaptation, routine outpatient resistance surveillance, structured evaluation, and sustainable support.

23 January 2025 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
JWJanina Soler Wenglein
Janina Soler Wenglein
ASArne Simon
Arne Simon
RBReinhard Berner
Reinhard Berner
HBHolger Brockmeyer
Holger Brockmeyer
JFJohannes Forster
Johannes Forster
RTRoland Tillmann
Roland Tillmann
In pediatric outpatient care, overuse and misuse of antibiotics is linked to a high risk of adverse events and increased antibiotic resistance. In 2019, building upon the work of the Antibiotic Therapy in Bielefeld (AnTiB) project (founded in 2016), a collaboration among the AnTiB, the German Society for Pediatric Infectious Diseases (DGPI), and the Professional Association of Outpatient Pediatricians and Adolescent Physicians (BVKJ) was established to develop consensus recommendations for antibiotic therapy in pediatric outpatient settings in Germany. This working group became the Antibiotic Stewardship in Outpatient Pediatrics (ABSaP). ABSaP institutes recommendations for antibiotic use in outpatient pediatric settings in Germany and updates them regularly. The ABSaP guidelines recommend restrictive, targeted, evidence-based prescription practices for antibiotics used to treat common infections among pediatric outpatients. This expert-driven, pragmatic, best-practice guidance is designed to be a living document. ABSaP’s most recent update was published in March 2024. The recommendations aim to guide and standardize rational antibiotics use by emphasizing the importance of avoiding unnecessary prescriptions, while also promoting the application of narrow-spectrum antibiotics, short-duration therapy, and watchful waiting, when treating mild, self-limiting infections in children without significant risk factors. Conclusions: ABSaP’s guidelines may provide a model for others, as well as offer a basis for discussing practical, effective antibiotic stewardship (ABS) measures in pediatric primary care. An international, expert consensus on ABS for pediatric outpatients could help promote a culture of responsible antibiotic use, improve prescribing safety, and contribute to broader ABS efforts. What is Known:• Overuse and misuse of antibiotics are associated with adverse events and increased antibiotic resistance, prompting the need for effective antibiotic stewardship initiatives.• The Antibiotic Stewardship in Outpatient Pediatrics (ABSaP) working group was established to develop and regularly update evidence-based best practice recommendations for the targeted and restrictive use of antibiotics in pediatric outpatient settings in Germany. What is New:• The most recent update of the ABSaP guidelines was published in March 2024, emphasizing the importance of narrow-spectrum antibiotics, short-duration therapy, and watchful waiting for mild infections, aiming to standardize rational antibiotic use in children.• The ABSaP guidelines have become widely accepted in Germany and are now being translated into English to foster international dialogue and collaboration on antibiotic stewardship in pediatric primary care, potentially serving as a model for similar initiatives in other countries.

25 April 2025 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
JWJanina Soler Wenglein
Janina Soler Wenglein
AHAndreas Heidenreich
Andreas Heidenreich
HFHendrik Friederichs
Hendrik Friederichs
Background: Information literacy depends on diverse skills in processing information, including understanding graphs properly. Especially for those advising and informing people with less information, health and graph literacy, it is important to achieve high competence in these areas themselves. Graph literacy, therefore, is a form of semiotic activity that is a crucial component of overall literacy for (future) physicians. We analyzed the graph literacy of undergraduate medical students to gain knowledge about their skills and potential areas for improvement. Methods: An observational cross-sectional survey study was performed with undergraduate medical students in their academic years 1 to 5 using the “Graph Literacy Scale.” It measures the participant’s ability to read and interpret graphically provided information with 13 questions in three dimensions regarding visual data: “reading the data,” “reading between the data,” and “reading beyond the data.” Participants can score between 0 and 13 points. Results: We obtained 449 complete questionnaires. Undergraduate medical students showed above-average test results compared to the German standard population, with an average score of 11.42 (SD = 1.42) vs. 9.4 points (SD = 2.6) points (p <.001). Although students generally scored high, one question measuring the ability to visually “read beyond the data” yielded significantly lower scores and showed variability regarding the participants’ performance compared to other questions of this category. Conclusions: While abilities in visually “reading the data” and “reading between the data” are high in our cohorts, their ability to visually “read beyond the data” is inconsistent. This requires attention in the training of medical students, as weaknesses in this area could lead to susceptibility to misleading data. Enhancing graph literacy in medical students is crucial for effective physician-patient communication.